Breast Cancer: Molecular Basis and Translational Research
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 27250
Special Issue Editor
Interests: metastatic breast cancer; advanced breast cancer; biomarkers; translational research; early phase clinical trials; triple-negative breast cancer; inflammatory breast cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We propose this Special Issue of “Breast Cancer: Molecular Basis and Translational Research” to cover the content about the pathogenic mechanism, novel omics-based biomarker assessment in breast cancer, and new therapeutic discoveries including pre-clinical studies. Given the importance of “bench-to-bedside translation” as a fundamental conduit of translational research in breast cancer, we will also cover topics such as liquid biopsy and other precision diagnostics in breast cancer that are under active developments. We will also include few review articles to share the current perspectives to compose the mix of original research data and reviews. We hope our Special Issue will attract studies that offer new insights into translational research in the field of breast cancer.
Dr. Bora Lim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metastatic breast cancer
- advanced breast cancer
- liquid biopsies
- novel omic assays in breast cancers
- translational research
- molecular diagnostic and therapies in breast cancers